Jiangxi Qingfeng Pharmaceutical Co. Ltd. clinical trials

A subsidiary of Qingfeng Pharmaceutical Group Co., Ltd.

The registry lists 32 studies whose lead sponsor is Jiangxi Qingfeng Pharmaceutical Co. Ltd.. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 4, 2026.

Studies

Recruiting first, then most recently updated. Showing 32 of 32. All Qingfeng Pharmaceutical Group Co., Ltd. studies →

• Study to Evaluate the Clinical Value and Safety of Xiyanping Injection in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease(COPD) Based on Real-world Clinical DataNot yet recruitingNCT06754865

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Study to Assess the Efficacy and Safety of GP681 Versus Placebo for Postexposure Prophylaxis Against InfluenzaRecruitingNCT06574503Phase 3

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Study of GP681 Tablets Compared With Placebo in Patients With Influenza at High Risk of Influenza ComplicationsRecruitingNCT06573008Phase 3

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Long-term Safety and Efficacy of Adjunctive Brivaracetam in Chinese Patients With Uncontrolled Focal EpilepsyCompletedNCT07563634Phase 3

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Study to Assess the Tolerability, Safety and Efficacy of GP681 Powder for Oral SuspensionCompletedNCT06643156Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Study to Assess Relative Bioavailability of GP681 Formulations in Healthy Chinese Male SubjectsCompletedNCT06678542Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• GP681 in Volunteers With Hepatic Impairment Compared With Healthy VolunteersCompletedNCT05814926Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• To Assess the Efficacy of GP681 Tablet Versus Placebo in Patients With Acute Uncomplicated Influenza Virus InfectionCompletedNCT05474755Phase 3

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Study to Evaluate the Drug-drug Interactions (DDIs) of GP681 With Rosuvastatin, Digoxin, Itraconazole, Oseltamivir in Chinese Healthy VolunteersCompletedNCT05789342Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute InfluenzaCompletedNCT04736758Phase 2

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Phase I Mass Balance Study of [14C]GP681 in Healthy Chinese Male VolunteersCompletedNCT05103241Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Efficacy and Safety of Intramuscular Injection of Xiyanping Injection in the Treatment of Acute Bronchitis in ChildrenStatus unknownNCT04926506Not applicable

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Phase I Study of BR790 in Subjects With Advanced Solid TumorsStatus unknownNCT04891653Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Study of SC10914 in Patients With gBRCA1/2 Mutation Advanced Ovarian CancerStatus unknownNCT04556539Phase 2

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Real World Study on the Efficacy and Safety of Lacosamide as Add-on Therapy for Focal-onset EpilepsyStatus unknownNCT04737837

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Evaluation the Safety and Tolerance of GP681 Tablets in Healthy SubjectsCompletedNCT04729764Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer PatientsStatus unknownNCT04556292Phase 2

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• SC10914 Monotherapy for the mCRPC With g/s BRCA MutationStatus unknownNCT04486937Phase 1/2

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Xiyanping Injection for the Treatment of New Coronavirus Infected PneumoniaStatus unknownNCT04275388

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Xiyanping Injection Combined With Azithromycin VS Azithromycin for Children With pneumoniaProtozoal PneumoniaStatus unknownNCT04296383Not applicable

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)Status unknownNCT04295551Not applicable

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Evaluation the Clinical Value of Xiyanping Injection in the Treatment of Community-acquired Pneumonia in ChildrenStatus unknownNCT04158310

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Healthy VolunteersStatus unknownNCT03641794Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS PatientsStatus unknownNCT03971383Phase 2

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like SymptomsStatus unknownNCT03947411Not applicable

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Study of Aolanti Weikang Tablets in Healthy VolunteersCompletedNCT03358485Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.Status unknownNCT02937857Phase 4

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Study of SC10914 in Patients With Advanced Solid TumorsStatus unknownNCT02940132Phase 1

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute BronchitisStatus unknownNCT03132623Phase 4

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute TonsillitisStatus unknownNCT03134443Phase 4

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic BronchitisStatus unknownNCT03132610Phase 4

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.

• Effectiveness and Safety of Chinese Medicine to Treat Hand, Foot, and Mouth DiseaseCompletedNCT01554930Not applicable

  Sponsor listed in the registry: Jiangxi Qingfeng Pharmaceutical Co. Ltd.